Cbl-transforming variants trigger a cascade of molecular alterations that lead to epithelial mesenchymal conversion - Wikidata - awgldk - TriplyDB

Cbl-transforming variants trigger a cascade of molecular alterations that lead to epithelial mesenchymal conversion

Cbl-transforming variants trigger a cascade of molecular alterations that lead to epithelial mesenchymal conversion

http://www.wikidata.org/entity/Q34764852

about

LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy Host-pathogen systems biology: logical modelling of hepatocyte growth factor and Helicobacter pylori induced c-Met signal transduction TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer.Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells Valproic acid, targets papillary thyroid cancer through inhibition of c-Met signalling pathway Beyond the RING: CBL proteins as multivalent adapters.Negative regulation of EGFR-Vav2 signaling axis by Cbl ubiquitin ligase controls EGF receptor-mediated epithelial cell adherens junction dynamics and cell migration.MET as a target for treatment of chest tumors Cbl ubiquitination of p85 is essential for Epo-induced EpoR endocytosis.Cbl-family proteins as regulators of cytoskeleton-dependent phenomena.MET: a new promising biomarker in non-small-cell lung carcinoma.A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation.Molecular Signatures of the Insulin-like Growth Factor 1-mediated Epithelial-Mesenchymal Transition in Breast, Lung and Gastric Cancers

P2860

Q24681561-E6DCAF33-1C67-4E83-A8CE-D9F73F579E6E Q33314672-4C1C8B58-B884-4590-A582-F25ED8E23702 Q33383797-316B4121-69EA-461C-9F75-BA29E98B1DD8 Q33736621-8A5B2A1B-D4DF-48DD-96BE-78FA99F057E7 Q33850376-A1C91413-B28C-4B7F-8D5B-AB91280D7DA7 Q34405560-D927577D-B856-4EA4-8307-0B2D8F45DA9B Q34452683-42D4995C-E2E4-4D31-8CBD-A41759313323 Q37232416-FF11B9AC-6C24-4F68-B33A-061AF6055FED Q37370673-24112C73-F4DD-4B1F-9109-ABA63ECA6A55 Q38112644-D3F576FD-AA13-4BD8-93C6-2E1DFB9FB928 Q38430194-9BC038CF-03A0-43BC-B224-DEA53AF456CF Q40559949-61D6F900-58B1-41A5-AE00-481DD3A63585 Q58776408-8850E1E2-3049-430A-A7D5-A09FB4F15704

P2860

Cbl-transforming variants trigger a cascade of molecular alterations that lead to epithelial mesenchymal conversion

http://www.wikidata.org/entity/Q34764852

description

2000 nî lūn-bûn

@nan

2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Cbl-transforming variants trig ...... thelial mesenchymal conversion

@ast

Cbl-transforming variants trig ...... thelial mesenchymal conversion

@en

Cbl-transforming variants trig ...... thelial mesenchymal conversion

@nl

type

label

Cbl-transforming variants trig ...... thelial mesenchymal conversion

@ast

Cbl-transforming variants trig ...... thelial mesenchymal conversion

@en

Cbl-transforming variants trig ...... thelial mesenchymal conversion

@nl

prefLabel

Cbl-transforming variants trig ...... thelial mesenchymal conversion

@ast

Cbl-transforming variants trig ...... thelial mesenchymal conversion

@en

Cbl-transforming variants trig ...... thelial mesenchymal conversion

@nl

P1433

Q34764852-7A46CEDF-E77A-4877-9A5F-6760484A177A

P1476

Q34764852-C0BD4110-0684-48D5-B832-E8C2290F8EB7

P2093

Q34764852-14915A4C-1D9A-4848-9161-CC3B34972784

Q34764852-63DA0314-BE25-42EE-AF43-313942B84A67

Q34764852-93B834A4-4413-4C34-BCF0-8B69674B41C9

Q34764852-B2C02F9D-37FE-4301-9F12-9D544EE86A1E

Q34764852-ECA146FE-1F04-46BF-B325-1C393B4F91E0

Q34764852-F202C644-802F-4600-BE69-F0D48599B0E3

Q34764852-F753AEC1-AAAD-4E10-A8B1-B01A0ECCFB43

P2860

Q34764852-0C3F132B-47BE-47F9-BAB4-A4B29C0F3751

Q34764852-119E6BC8-9D3C-4177-AFE4-1465904D20DA

Q34764852-165365A3-9EE8-49C1-9056-6E42C54A9EEC

Q34764852-17F2DE85-91FA-490A-B679-6695DAECF290

Q34764852-1BAAB31E-4F57-456C-BCC5-908EBF04FA84

Q34764852-1F32455B-C9CC-4C50-BFD6-3843806B2803

Q34764852-26CC741A-5CE3-4AAA-80B2-DB1F3CCC3654

Q34764852-2F8ED5A6-8072-458C-B4EC-6F6F5493E6A1

Q34764852-2F9842BA-5999-4EB9-8032-52330B7ADD74

Q34764852-35D75AE8-F017-4EBE-BC63-0B4B192ACE9E

P304

Q34764852-858BCFC7-1EE5-4B5C-9811-77C8DC1C1FC6

P31

Q34764852-BA22C263-A781-4D62-AE56-170A69B45D0A

P356

Q34764852-6278F426-3DFF-4D19-8342-CAE649A4745F

P433

Q34764852-9F143AAC-95AB-42E5-8ACA-B7CF233C488D

P478

Q34764852-9CA0F93D-8AE2-43B0-B4CC-09E7C57E0580

P577

Q34764852-3A181865-BCEE-4603-8E41-B60735FC32EE

P5875

Q34764852-50EC3767-1827-421A-BEC4-1DEBC875ACE8

P698

Q34764852-74F1898E-D1A1-43CA-B9E1-4EA7DB2405CB

P932

Q34764852-3D698DFE-FBAC-46C1-BFDD-9AC68E534F59

P356

P1433

Molecular Biology of the Cell

P1476

Cbl-transforming variants trig ...... thelial mesenchymal conversion

@en

P2093

C R Maroun

http://www.w3.org/2001/XMLSchema#string

H Band

http://www.w3.org/2001/XMLSchema#string

L Lamorte

http://www.w3.org/2001/XMLSchema#string

M Lupher

http://www.w3.org/2001/XMLSchema#string

M Park

http://www.w3.org/2001/XMLSchema#string

T M Fournier

http://www.w3.org/2001/XMLSchema#string

W Langdon

http://www.w3.org/2001/XMLSchema#string

P2860

Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase

A Grb2-associated docking protein in EGF- and insulin-receptor signalling

The Gab1 PH domain is required for localization of Gab1 at sites of cell-cell contact and epithelial morphogenesis downstream from the met receptor tyrosine kinase

v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas

Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity

Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase

Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase

The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase

Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7

A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells

P304

3397-3410

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1091/MBC.11.10.3397

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2000-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12295420

http://www.w3.org/2001/XMLSchema#string

P698

11029044

http://www.w3.org/2001/XMLSchema#string

P932

15002

http://www.w3.org/2001/XMLSchema#string